Literature DB >> 23847188

MGUS prevalence in a cohort of AML patients.

S Peter Wu, Rene Costello, Jonathan N Hofmann, Neha Korde, Sham Mailankody, Mark Purdue, Ola Landgren.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23847188      PMCID： PMC3709656          DOI： 10.1182/blood-2013-04-497859

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  12 in total

1.  MULTIPLE MYELOMA I. THE PATHOGENESIS OF "AMYLOIDOSIS.

Authors:  E F OSSERMAN; K TAKATSUKI; N TALAL
Journal:  Semin Hematol       Date:  1964-01       Impact factor: 3.851

2.  Polyclonal immunoglobulin free light chains as a potential biomarker of immune stimulation and inflammation.

Authors:  Colin A Hutchison; Ola Landgren
Journal:  Clin Chem       Date:  2011-10       Impact factor: 8.327

3.  Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study.

Authors:  Angela Dispenzieri; Jerry A Katzmann; Robert A Kyle; Dirk R Larson; L Joseph Melton; Colin L Colby; Terry M Therneau; Raynell Clark; Shaji K Kumar; Arthur Bradwell; Rafael Fonseca; D F Jelinek; S Vincent Rajkumar
Journal:  Lancet       Date:  2010-05-15       Impact factor: 79.321

4.  Multiple myeloma and acute myelomonocytic leukemia.

Authors:  R A Kyle; R V Pierre; E D Bayrd
Journal:  N Engl J Med       Date:  1970-11-19       Impact factor: 91.245

5.  The chemotherapy on plasma-cell myeloma and the incidence of acute leukemia.

Authors:  D E Bergsagel; A J Bailey; G R Langley; R N MacDonald; D F White; A B Miller
Journal:  N Engl J Med       Date:  1979-10-04       Impact factor: 91.245

6.  Evidence of serum immunoglobulin abnormalities up to 9.8 years before diagnosis of chronic lymphocytic leukemia: a prospective study.

Authors:  Huei-Ting Tsai; Neil E Caporaso; Robert A Kyle; Jerry A Katzmann; Angela Dispenzieri; Richard B Hayes; Gerald E Marti; Maher Albitar; Paolo Ghia; S Vincent Rajkumar; Ola Landgren
Journal:  Blood       Date:  2009-10-14       Impact factor: 22.113

Review 7.  International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders.

Authors:  A Dispenzieri; R Kyle; G Merlini; J S Miguel; H Ludwig; R Hajek; A Palumbo; S Jagannath; J Blade; S Lonial; M Dimopoulos; R Comenzo; H Einsele; B Barlogie; K Anderson; M Gertz; J L Harousseau; M Attal; P Tosi; P Sonneveld; M Boccadoro; G Morgan; P Richardson; O Sezer; M V Mateos; M Cavo; D Joshua; I Turesson; W Chen; K Shimizu; R Powles; S V Rajkumar; B G M Durie
Journal:  Leukemia       Date:  2008-11-20       Impact factor: 11.528

8.  Multiple myeloma and acute leukemia associated with alkylating agents.

Authors:  R A Kyle; R V Pierre; E D Bayrd
Journal:  Arch Intern Med       Date:  1975-01

9.  Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.

Authors:  Jerry A Katzmann; Raynell J Clark; Roshini S Abraham; Sandra Bryant; James F Lymp; Arthur R Bradwell; Robert A Kyle
Journal:  Clin Chem       Date:  2002-09       Impact factor: 8.327

10.  A comparison of the incidence of the myelodysplastic syndrome and acute myeloid leukaemia following melphalan and cyclophosphamide treatment for myelomatosis. A report to the Medical Research Council's working party on leukaemia in adults.

Authors:  J Cuzick; S Erskine; D Edelman; D A Galton
Journal:  Br J Cancer       Date:  1987-05       Impact factor: 7.640
View more
  1 in total

1.  Risk of myeloid neoplasms after solid organ transplantation.

Authors:  L M Morton; T M Gibson; C A Clarke; C F Lynch; L A Anderson; R Pfeiffer; O Landgren; D D Weisenburger; E A Engels
Journal:  Leukemia       Date:  2014-04-14       Impact factor: 12.883
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.